T. Clark Gamblin
No Rating Available
(Learn About Our Rating System)

T. Clark Gamblin, MD, MS, MBA, FACS

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

1950 Circle of Hope
Salt Lake City , UT 84112
801-585-6911
Get Directions

  • T. Clark Gamblin, MD, MS, MBA, FACS, is a surgical oncologist specializing in complex gastrointestinal (GI) cancers, with expertise in liver, biliary, pancreas, gastric, sarcoma, and peritoneal-based malignancies. He is nationally recognized for leading regional therapies for advanced cancer and pioneering surgical approaches for liver cancer. Dr. Gamblin currently serves as the Chief of the Division of Surgical Oncology at the University of Utah at the Huntsman Cancer Institute.

    Clinical Expertise

    Dr. Gamblin’s practice focuses on:

    • GI Surgical Oncology

    • Liver Surgery (including benign liver tumors and biliary reconstruction)

    • Biliary and Gallbladder Surgery and Benign Biliary Disease

    • Pancreatic Surgery

    • Gastric (Stomach) Cancer Surgery

    • Sarcoma Surgery

    • Cytoreductive Surgery with HIPEC (Hyperthermic Intraperitoneal Chemotherapy)

    • Neuroendocrine Cancer

    • Laparoscopic and Robotic Surgical Oncology

    Education and Training

    Dr. Gamblin earned his medical degree at the University of Mississippi Medical Center and completed General Surgery training at Mercer University. He then pursued a Surgical Oncology fellowship at the University of Pittsburgh, where he also earned a Master of Science in Clinical Research, led liver cancer clinical trials, and directed the Neuroendocrine Cancer Program.

    Following his fellowship, Dr. Gamblin joined the Medical College of Wisconsin (MCW) as the inaugural Chief of Surgical Oncology, where he built and expanded programs in complex surgical oncology and grew the division to a national leader. While at MCW, he also completed an MBA at the Kellogg School of Management, Northwestern University.

    Patient Care Philosophy

    Dr. Gamblin believes in partnering with patients and families to educate, guide, and optimize care. He works with a multidisciplinary team to provide thoughtfully aggressive treatments, aiming to eradicate cancer while treating patients with the highest level of respect and compassion.

    Research

    Dr. Gamblin’s research focuses on outcomes in liver and peritoneal-based malignancies, with a particular emphasis on therapies for advanced cancers and improving patient quality of life. He is focused on hepatobiliary disease presentation, management and optimal outcomes using institutional and large datasets. He is also interested in providing state-of-the- art clinic trials and defining care for the tomorrow's patients.

    Personal Interests

    Outside of medicine, Dr. Gamblin is an avid runner, reader, camper, and outdoorsman, enjoying time in nature and staying active with his wife and dog Ruby.

    Specialties

    Board Certification

    American Board of Surgery

  • T. Clark Gamblin, MD, MS, MBA, FACS, is a surgical oncologist specializing in complex gastrointestinal (GI) cancers, with expertise in liver, biliary, pancreas, gastric, sarcoma, and peritoneal-based malignancies. He is nationally recognized for leading regional therapies for advanced cancer and pioneering surgical approaches for liver cancer. Dr. Gamblin currently serves as the Chief of the Division of Surgical Oncology at the University of Utah at the Huntsman Cancer Institute.

    Clinical Expertise

    Dr. Gamblin’s practice focuses on:

    • GI Surgical Oncology

    • Liver Surgery (including benign liver tumors and biliary reconstruction)

    • Biliary and Gallbladder Surgery and Benign Biliary Disease

    • Pancreatic Surgery

    • Gastric (Stomach) Cancer Surgery

    • Sarcoma Surgery

    • Cytoreductive Surgery with HIPEC (Hyperthermic Intraperitoneal Chemotherapy)

    • Neuroendocrine Cancer

    • Laparoscopic and Robotic Surgical Oncology

    Education and Training

    Dr. Gamblin earned his medical degree at the University of Mississippi Medical Center and completed General Surgery training at Mercer University. He then pursued a Surgical Oncology fellowship at the University of Pittsburgh, where he also earned a Master of Science in Clinical Research, led liver cancer clinical trials, and directed the Neuroendocrine Cancer Program.

    Following his fellowship, Dr. Gamblin joined the Medical College of Wisconsin (MCW) as the inaugural Chief of Surgical Oncology, where he built and expanded programs in complex surgical oncology and grew the division to a national leader. While at MCW, he also completed an MBA at the Kellogg School of Management, Northwestern University.

    Patient Care Philosophy

    Dr. Gamblin believes in partnering with patients and families to educate, guide, and optimize care. He works with a multidisciplinary team to provide thoughtfully aggressive treatments, aiming to eradicate cancer while treating patients with the highest level of respect and compassion.

    Research

    Dr. Gamblin’s research focuses on outcomes in liver and peritoneal-based malignancies, with a particular emphasis on therapies for advanced cancers and improving patient quality of life. He is focused on hepatobiliary disease presentation, management and optimal outcomes using institutional and large datasets. He is also interested in providing state-of-the- art clinic trials and defining care for the tomorrow's patients.

    Personal Interests

    Outside of medicine, Dr. Gamblin is an avid runner, reader, camper, and outdoorsman, enjoying time in nature and staying active with his wife and dog Ruby.

    Board Certification and Academic Information

    Academic Departments Surgery -Professor
    Academic Divisions Surgical Oncology
    Board Certification
    American Board of Surgery

    Education history

    Graduate Training Northwestern University Kellogg School of Management M.B.A.
    Graduate Training University of Pittsburgh M.S.
    Fellowship Surgical Oncology - University of Pittsburgh School of Medicine Fellow
    Residency General Surgery - Mercer University School of Medicine Resident
    Professional Medical Medicine - University of Mississippi School of Medicine M.D.
    Undergraduate Mississippi State University B.S.

    Selected Publications

    Journal Article

    1. ORorke M, Chrischilles E, NETPRO Study Investigators (2024). Making progress against rare cancers: A case study on neuroendocrine tumors. Cancer, 130(9), 1568-1574. (Read full publication)
    2. Merrill JR, Flitcroft MA, Miller T, Beichner B, Clarke CN, Maduekwe UN, Wang TS, Dream S, Christians KK, Gamblin TC, Evans DB, Kothari AN (2023). Patterns of Unnecessary Insurer Prior Authorization Denials in a Complex Surgical Oncology Practice. J Surg Res, 288, 269-274. (Read full publication)
    3. Servin-Rojas M, Shafique N, Sell NM, Gamblin TC, Qadan M (2023). Facility type is associated with improved perioperative and oncologic outcomes after minimally invasive surgery for pancreatic cancer. HPB (Oxford), 25(8), 933-940. (Read full publication)
    4. SenthilKumar G, Madhusudhana S, Flitcroft M, Sheriff S, Thalji S, Merrill J, Clarke CN, Maduekwe UN, Tsai S, Christians KK, Gamblin TC, Kothari AN (2023). Automated machine learning (AutoML) can predict 90-day mortality after gastrectomy for cancer. Sci Rep, 13(1), 11051. (Read full publication)
    5. Thalji SZ, Ethun CG, Tsai S, Gamblin TC, Clarke CN, Bedi M, King D, LoGiudice J, Poultsides G, Grignol VP, Tseng J, Votanopoulos K, Fields RC, Cardona K, Mogal H (2022). Outcomes of plastic surgical reconstruction in extremity and truncal soft tissue sarcoma: Results from the US Sarcoma Collaborative. J Surg Oncol, 127(4), 550-559. (Read full publication)
    6. Strong EA, Livingston A, Gracz M, Peltier W, Tsai S, Christians K, Gamblin TC, Kersting K, Clarke CN (2022). Palliative Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis: Is It Safe and Effective? J Surg Res, 278, 31-38. (Read full publication)
    7. Chrabaszcz S, Rajeev R, Witmer HDD, Dhiman A, Klooster B, Gamblin TC, Banerjee A, Johnston FM, Turaga KK (2022). A Systematic Review of Conversion to Resectability in Unresectable Metastatic Colorectal Cancer Chemotherapy Trials. Am J Clin Oncol, 45(8), 366-372. (Read full publication)
    8. Franssen S, Soares KC, Jolissaint JS, Tsilimigras DI, Buettner S, Alexandrescu S, Marques H, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Margonis GA, Weiss MJ, Bauer TW, Shen F, Poultsides GA, Marsh JW, Cercek A, Kemeny N, Kingham TP, DAngelica M, Pawlik TM, Jarnagin WR, Koerkamp BG (2022). Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma. JAMA Surg, 157(7), 590-596. (Read full publication)
    9. Fackche N, Schmocker RK, Kubi B, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Powers B, Dineen S, Veerapong J, Baumgartner JM, Clarke C, Gamblin TC, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Zaidi MY, Maithel SK, Johnston FM, Greer JB (2021). The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative. J Gastrointest Surg, 25(11), 2908-2919. (Read full publication)
    10. Chavez MI, Gholami S, Kim BJ, Margonis GA, Ethun CG, Tsai S, Christians KK, Clarke C, Mogal H, Maithel SK, Pawlik TM, DAngelica MI, Aloia TA, Eastwood D, Gamblin TC (2021). Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis. Ann Surg Oncol, 28(3), 1457-1465. (Read full publication)
    11. Chouliaras K, Patel N, Senehi R, Ethun CG, Poultsides G, Grignol V, Gamblin TC, Roggin KK, Fields RC, DAgostino R Jr, Levine EA, Cardona K, Votanopoulos K (2020). Impact of resection margin on outcomes in high-grade soft tissue sarcomas of the extremity-A USSC analysis. J Surg Oncol, 123(2), 479-488. (Read full publication)
    12. Strong EA, Park SH, Ethun CG, Chow B, King D, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Gamblin TC, Cardona K, Clarke CN (2020). High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma. Surgery, 168(4), 760-767. (Read full publication)
    13. Lee RM, Ethun CG, Zaidi MY, Tran TB, Poultsides GA, Grignol VP, Howard JH, Bedi M, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Oskouei SV, Monson DK, Reimer NB, Maithel SK, Cardona K (2020). A closer look at the natural history and recurrence patterns of high-grade truncal/extremity leiomyosarcomas: A multi-institutional analysis from the US Sarcoma Collaborative. Surg Oncol, 34, 292-297. (Read full publication)
    14. Liu C, Rein L, Clarke C, Mogal H, Tsai S, Christians KK, Gamblin TC (2020). Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base. J Surg Oncol, 122(2), 176-182. (Read full publication)
    15. Thalji SZ, Tsai S, Gamblin TC, Clarke C, Christians K, Charlson J, Ethun CG, Poultsides G, Grignol VP, Roggin KK, Votanopoulos K, Fields RC, Abbott DE, Cardona K, Mogal H, other members of the US Sarcoma Collaborative (2020). Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative. J Surg Oncol, 121(7), 1140-1147. (Read full publication)
    16. Chicago Consensus Working Group (2020). The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms. Cancer, 126(11), 2525-2533. (Read full publication)
    17. Chicago Consensus Working Group (2020). The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors. Ann Surg Oncol, 27(6), 1793-1797. (Read full publication)
    18. Chicago Consensus Working Group (2020). The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases. Ann Surg Oncol, 27(6), 1768-1773. (Read full publication)
    19. Chicago Consensus Working Group (2020). The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms. Ann Surg Oncol, 27(6), 1780-1787. (Read full publication)
    20. Chicago Consensus Working Group (2020). The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations. Ann Surg Oncol, 27(6), 1798-1804. (Read full publication)
    21. Chicago Consensus Working Group (2020). The Chicago Consensus on Peritoneal Surface Malignancies: Standards. Ann Surg Oncol, 27(6), 1743-1752. (Read full publication)
    22. Coon C, Berger N, Eastwood D, Tsai S, Christians K, Mogal H, Clarke C, Gamblin TC (2019). Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy. Ann Surg Oncol, 27(4), 1156-1163. (Read full publication)
    23. Gamboa AC, Zaidi MY, Lee RM, Speegle S, Switchenko JM, Lipscomb J, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers BD, Lowy AM, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Lambert L, Hendrix RJ, Abbott DE, Vande Walle K, Lafaro K, Lee B, Johnston FM, Greer J, Russell MC, Staley CA, Maithel SK (2019). Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative. Ann Surg Oncol, 27(1), 134-146. (Read full publication)
    24. Squires MH, Ethun CG, Suarez-Kelly LP, Yu PY, Hughes TM, Shelby RD, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH (2019). Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas. J Surg Res, 245, 577-586. (Read full publication)
    25. Zaidi MY, Lee RM, Gamboa AC, Speegle S, Cloyd JM, Kimbrough C, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Dessureault S, Kelly KJ, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Hendrix RJ, Lambert L, Ronnekleiv-Kelly S, Pokrzywa C, Blakely AM, Lee B, Johnston FM, Fackche N, Russell MC, Maithel SK, Staley CA 3rd (2019). Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative. Ann Surg Oncol, 27(1), 156-164. (Read full publication)
    26. Buettner S, Ten Cate DWG, Bagante F, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Margonis GA, Weiss M, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JNM, Pawlik TM, Koerkamp BG (2019). Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma. J Gastrointest Surg, 23(11), 2239-2246. (Read full publication)
    27. Lee GC, Gamblin TC, Fong ZV, Ferrone CR, Goyal L, Lillemoe KD, Blaszkowsky LS, Tanabe KK, Qadan M (2019). Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma. Ann Surg Oncol, 26(12), 4091-4099. (Read full publication)
    28. Gamboa AC, Ethun CG, Switchenko JM, Lipscomb J, Poultsides GA, Grignol V, Howard JH, Gamblin TC, Roggin KK, Votanopoulos K, Fields RC, Maithel SK, Delman KA, Cardona K (2019). Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: Chest X-Ray or CT Scan? J Am Coll Surg, 229(5), 449-457. (Read full publication)
    29. Chouliaras K, Senehi R, Ethun CG, Poultsides G, Tran T, Grignol V, Gamblin TC, Roggin KK, Tseng J, Fields RC, Weber SM, Russell GB, Levine EA, Cardona K, Votanopoulos K (2019). Recurrence patterns after resection of retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. J Surg Oncol, 120(3), 340-347. (Read full publication)
    30. Morgan Z, Chow BE, Strong EA, Tsai S, Christians K, Mogal H, Gamblin TC, Clarke CN (2019). RAS Mutation Status Confers Prognostic Relevance in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer. J Surg Res, 240, 130-135. (Read full publication)
    31. Engelsgjerd S, Kunnimalaiyaan S, Kandil E, Gamblin TC, Kunnimalaiyaan M (2019). Xanthohumol increases death receptor 5 expression and enhances apoptosis with the TNF-related apoptosis-inducing ligand in neuroblastoma cell lines. PLoS One, 14(3), e0213776. (Read full publication)
    32. Engelsgjerd S, Kunnimalaiyaan S, Kandil E, Gamblin TC, Kunnimalaiyaan M (2019). Xanthohumol increases death receptor 5 expression and enhances apoptosis with the TNF-related apoptosis-inducing ligand in neuroblastoma cell lines. PLoS One, 14(3), e0213776. (Read full publication)
    33. Silva JP, Maurina MN, Tsai S, Christians KK, Clarke CN, Mogal H, Saeian K, Gamblin TC (2019). Effect of Donor Race-Matching on Overall Survival for African-American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma. J Am Coll Surg, 228(3), 245-254. (Read full publication)
    34. Robbins JR, Schmid RK, Hammad AY, Gamblin TC, Erickson BA (2019). Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival. Cancer Med, 8(3), 928-938. (Read full publication)
    35. Sherman SK, Lange JJ, Dahdaleh FS, Rajeev R, Gamblin TC, Polite BN, Turaga KK (2018). Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer. JAMA Oncol, 5(2), 236-242. (Read full publication)
    36. Wilkinson KH, Ethun CG, Hembrook M, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Weber S, Gamblin TC, Cardona K, Clarke CN (2018). Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative. J Surg Res, 233, 154-162. (Read full publication)
    37. Yu PY, Beal EW, Hughes TM, Suarez-Kelly LP, Shelby RD, Ethun CG, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH (2018). Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma. J Surg Res, 231, 248-256. (Read full publication)
    38. Buettner S, Spolverato G, Kimbrough CW, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Weiss M, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JNM, Koerkamp BG, Pawlik TM (2018). The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma. Surgery, 164(3), 411-418. (Read full publication)
    39. Johnson AC, Ethun CG, Liu Y, Lopez-Aguiar AG, Tran TB, Poultsides G, Grignol V, Howard JH, Bedi M, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Delman KA, Wood WC, Cardona K, Maithel SK (2018). Studying a Rare Disease Using Multi-Institutional Research Collaborations vs Big Data: Where Lies the Truth? J Am Coll Surg, 227(3), 357-366.e3. (Read full publication)
    40. Berger NG, Herren JL, Liu C, Burrow RH, Silva JP, Tsai S, Christians KK, Gamblin TC (2018). Ablation approach for primary liver tumors: Peri-operative outcomes. J Surg Oncol, 117(7), 1493-1499. (Read full publication)
    41. Liu C, Berger NG, Rein L, Tarima S, Clarke C, Mogal H, Christians KK, Tsai S, Gamblin TC (2018). Gallbladder carcinoma: An analysis of the national cancer data base to examine hispanic influence. J Surg Oncol, 117(8), 1664-1671. (Read full publication)
    42. Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC (2018). The effect of prior upper abdominal surgery on outcomes after liver transplantation for hepatocellular carcinoma: An analysis of the database of the organ procurement transplant network. Surgery, 163(5), 1028-1034. (Read full publication)
    43. Berger NG, Silva JP, Mogal H, Clarke CN, Bedi M, Charlson J, Christians KK, Tsai S, Gamblin TC (2017). Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base. Surgery, 163(2), 318-323. (Read full publication)
    44. Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians KK, Clarke CN, Mogal H, Clark Gamblin T (2017). Minimally invasive hepatectomy conversions: an analysis of risk factors and outcomes. HPB (Oxford), 20(2), 132-139. (Read full publication)
    45. Buettner S, Galjart B, van Vugt JLA, Bagante F, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Margonis GA, Weiss M, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JNM, Groot Koerkamp B, Pawlik TM (2017). Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma. J Surg Oncol, 116(8), 1085-1095. (Read full publication)
    46. Silva JP, Gorman RA, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC (2017). The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients. J Surg Oncol, 116(7), 831-840. (Read full publication)
    47. Jayakrishnan TT, Sekigami Y, Rajeev R, Gamblin TC, Turaga KK (2016). Morbidity of curative cancer surgery and suicide risk. Psychooncology, 26(11), 1792-1798. (Read full publication)
    48. Berger NG, Tanious MN, Hammad AY, Miura JT, Mogal H, Clarke CN, Christians KK, Tsai S, Gamblin TC (2017). External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database. J Surg Oncol, 116(3), 307-312. (Read full publication)
    49. Silva JP, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, White S, Rilling W, Gamblin TC (2017). Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis. HPB (Oxford), 19(8), 659-666. (Read full publication)
    50. Morris RS, Gani F, Hammad AY, Peltier W, Gamblin TC, Turaga KK, Johnston FM (2016). Factors associated with palliative care use in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Res, 211, 79-86. (Read full publication)
    51. Kunnimalaiyaan S, Sokolowski K, Gamblin TC, Kunnimalaiyaan M (2016). Suberoylanilide hydroxamic Acid, a histone deacetylase inhibitor, alters multiple signaling pathways in hepatocellular carcinoma cell lines. Am J Surg, 213(4), 645-651. (Read full publication)
    52. Buettner S, Koerkamp BG, Ejaz A, Buisman FE, Kim Y, Margonis GA, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JN, Pawlik TM (2017). The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis. J Surg Oncol, 115(3), 312-318. (Read full publication)
    53. Hammad AY, Robbins JR, Turaga KK, Christians KK, Gamblin TC, Johnston FM (2016). Palliative interventions for hepatocellular carcinoma patients: analysis of the National Cancer Database. Ann Palliat Med, 6(1), 26-35. (Read full publication)
    54. Hammad AY, Berger NG, Eastwood D, Tsai S, Turaga KK, Christian KK, Johnston FM, Pawlik TM, Gamblin TC (2016). Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival. Ann Surg Oncol, 23(Suppl 5), 912-920. (Read full publication)
    55. Margonis GA, Buettner S, Sasaki K, Kim Y, Ratti F, Russolillo N, Ferrero A, Berger N, Gamblin TC, Poultsides G, Tran T, Postlewait LM, Maithel S, Michaels AD, Bauer TW, Marques H, Barroso E, Aldrighetti L, Pawlik TM (2016). The role of liver-directed surgery in patients with hepatic metastasis from primary breast cancer: a multi-institutional analysis. HPB (Oxford), 18(8), 700-5. (Read full publication)
    56. Sekigami Y, Rajeev R, Johnston F, Clark Gamblin T, Turaga KK (2016). Conditional Survival as a Patient Centered Metric for Patients with Appendiceal Adenocarcinoma. Ann Surg Oncol, 23(7), 2295-301. (Read full publication)
    57. Bagante F, Spolverato G, Cucchetti A, Gani F, Popescu I, Ruzzenente A, Marques HP, Aldrighetti L, Gamblin TC, Maithel SK, Sandroussi C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Guglielmi A, Pawlik TM (2016). Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysis. Surgery, 160(1), 106-117. (Read full publication)
    58. Philips P, Groeschl RT, Hanna EM, Swan RZ, Turaga KK, Martinie JB, Iannitti DA, Schmidt C, Gamblin TC, Martin RC (2016). Single-stage resection and microwave ablation for bilobar colorectal liver metastases. Br J Surg, 103(8), 1048-54. (Read full publication)
    59. Kashtan MA, Jayakrishnan TT, Rajeev R, Charlson JC, Johnston F, Clark Gamblin T, Turaga KK (2015). Age-based disparities in treatment and outcomes of retroperitoneal rhabdomyosarcoma. Int J Clin Oncol, 21(3), 602-8. (Read full publication)
    60. Margonis GA, Samaha M, Kim Y, Postlewait LM, Kunz P, Maithel S, Tran T, Berger N, Gamblin TC, Mullen MG, Bauer TW, Pawlik TM (2016). A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis. J Gastrointest Surg, 20(6), 1098-105. (Read full publication)
    61. Klooster B, Rajeev R, Chrabaszcz S, Charlson J, Miura J, Bedi M, Gamblin TC, Johnston F, Turaga KK (2016). Is long-term survival possible after margin-positive resection of retroperitoneal sarcoma (RPS)? J Surg Oncol, 113(7), 823-7. (Read full publication)
    62. Shivakumar N, Hammad AY, Gamblin TC (2016). Frank Netter: A Man of Art and Science. Am Surg, 82(5), 377-9. (Read full publication)
    63. Sokolowski KM, Balamurugan M, Kunnimalaiyaan S, Wilson J, Gamblin TC, Kunnimalaiyaan M (2016). Role of Akt inhibition on Notch1 expression in hepatocellular carcinoma: potential role for dual targeted therapy. Am J Surg, 211(4), 755-60. (Read full publication)
    64. Nadeem H, Jayakrishnan TT, Rajeev R, Johnston FM, Gamblin TC, Turaga KK (2016). Cost Differential of Chemotherapy for Solid Tumors. J Oncol Pract, 12(3), e299-307, 251. (Read full publication)
    65. Vitale A, Spolverato G, Bagante F, Gani F, Popescu I, Marques HP, Aldrighetti L, Gamblin TC, Maithel SK, Sandroussi C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik TM (2016). A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma. J Surg Oncol, 113(4), 420-6. (Read full publication)
    66. Ferrone CR, Ting DT, Shahid M, Konstantinidis IT, Sabbatino F, Goyal L, Rice-Stitt T, Mubeen A, Arora K, Bardeesey N, Miura J, Gamblin TC, Zhu AX, Borger D, Lillemoe KD, Rivera MN, Deshpande V (2014). The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology. Ann Surg Oncol, 23(1), 290-6. (Read full publication)
    67. Spolverato G, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Clark Gamblin T, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Tran TB, Wallis Marsh J, Pawlik TM (2015). Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection. Ann Surg Oncol, 23(1), 235-43. (Read full publication)
    68. Ang C, Miura JT, Gamblin TC, He R, Xiu J, Millis SZ, Gatalica Z, Reddy SK, Yee NS, Abou-Alfa GK (2015). Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options. J Surg Oncol, 113(1), 55-61. (Read full publication)
    69. Glenn JA, Turaga KK, Gamblin TC, Hohmann SF, Johnston FM (2015). Minimally invasive gastrectomy for cancer: current utilization in US academic medical centers. Surg Endosc, 29(12), 3768-75. (Read full publication)
    70. Marcus RK, Geurts JL, Grzybowski JA, Turaga KK, Clark Gamblin T, Strong KA, Johnston FM (2015). Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines. Fam Cancer, 14(4), 641-9. (Read full publication)
    71. Larrieux G, Wachi BI, Miura JT, Turaga KK, Christians KK, Gamblin TC, Peltier WL, Weissman DE, Nattinger AB, Johnston FM (2015). Palliative Care Training in Surgical Oncology and Hepatobiliary Fellowships: A National Survey of Program Directors. Ann Surg Oncol, 22 Suppl 3, S1181-6. (Read full publication)
    72. Potkonjak M, Miura JT, Turaga KK, Johnston FM, Tsai S, Christians KK, Gamblin TC (2015). Intrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy. HPB (Oxford), 17(12), 1119-23. (Read full publication)
    73. Bagante F, Gani F, Spolverato G, Xu L, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik TM (2015). Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy. J Am Coll Surg, 221(6), 1031-40.e1-4. (Read full publication)
    74. Spolverato G, Vitale A, Cucchetti A, Popescu I, Marques HP, Aldrighetti L, Gamblin TC, Maithel SK, Sandroussi C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik TM (2015). Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma? Cancer, 121(22), 3998-4006. (Read full publication)
    75. Spolverato G, Yakoob MY, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik TM (2015). The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol, 22(12), 4020-8. (Read full publication)
    76. Zacharias AJ, Jayakrishnan TT, Rajeev R, Rilling WS, Thomas JP, George B, Johnston FM, Gamblin TC, Turaga KK (2015). Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-Analysis. PLoS One, 10(10), e0139940. (Read full publication)
    77. Miura JT, Johnston FM, Tsai S, George B, Thomas J, Eastwood D, Banerjee A, Christians KK, Turaga KK, Pawlik TM, Clark Gamblin T (2015). Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma. Ann Surg Oncol, 22(11), 3716-23. (Read full publication)
    78. Miura JT, Johnston FM, Tsai S, Eastwood D, Banerjee A, Christians KK, Turaga KK, Gamblin TC (2015). Surgical resection versus ablation for hepatocellular carcinoma ≤ 3 cm: a population-based analysis. HPB (Oxford), 17(10), 896-901. (Read full publication)
    79. Miura JT, Charlson J, Gamblin TC, Eastwood D, Banerjee A, Johnston FM, Turaga KK (2015). Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma. Eur J Surg Oncol, 41(10), 1386-92. (Read full publication)
    80. Kunnimalaiyaan S, Gamblin TC, Kunnimalaiyaan M (2015). Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression. HPB (Oxford), 17(9), 770-6. (Read full publication)
    81. Spolverato G, Yakoob MY, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik TM (2015). Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma. Cancer, 121(16), 2730-9. (Read full publication)
    82. Ferretti S, Tranchart H, Buell JF, Eretta C, Patriti A, Spampinato MG, Huh JW, Vigano L, Han HS, Ettorre GM, Jovine E, Gamblin TC, Belli G, Wakabayashi G, Gayet B, Dagher I (2015). Laparoscopic Simultaneous Resection of Colorectal Primary Tumor and Liver Metastases: Results of a Multicenter International Study. World J Surg, 39(8), 2052-60. (Read full publication)
    83. Miura JT, Rilling WS, White SB, Hieb RA, Tutton SM, Patel PJ, Gamblin TC, Hohenwalter EJ (2015). Safety and efficacy of transarterial chemoembolization in patients with transjugular intrahepatic portosystemic shunts. HPB (Oxford), 17(8), 707-12. (Read full publication)
    84. Spolverato G, Kim Y, Alexandrescu S, Popescu I, Marques HP, Aldrighetti L, Clark Gamblin T, Miura J, Maithel SK, Squires MH, Pulitano C, Sandroussi C, Mentha G, Bauer TW, Newhook T, Shen F, Poultsides GA, Wallis Marsh J, Pawlik TM (2014). Is Hepatic Resection for Large or Multifocal Intrahepatic Cholangiocarcinoma Justified? Results from a Multi-Institutional Collaboration. Ann Surg Oncol, 22(7), 2218-25. (Read full publication)
    85. Spolverato G, Maqsood H, Vitale A, Alexandrescu S, Marques HP, Aldrighetti L, Gamblin TC, Pulitano C, Bauer TW, Shen F, Poultsides G, Maithel S, Marsh JW, Pawlik TM (2015). Readmission After Liver Resection for Intrahepatic Cholangiocarcinoma: a Multi-Institutional Analysis. J Gastrointest Surg, 19(7), 1334-41. (Read full publication)
    86. Bischof DA, Dodson R, Jimenez MC, Behman R, Cocieru A, Blazer DG 3rd, Fisher SB, Squires MH 3rd, Kooby DA, Maithel SK, Groeschl RT, Gamblin TC, Bauer TW, Karanicolas PJ, Law C, Quereshy FA, Pawlik TM (2015). Adherence to Guidelines for Adjuvant Imatinib Therapy for GIST: A Multi-institutional Analysis. J Gastrointest Surg, 19(6), 1022-8. (Read full publication)
    87. Bischof DA, Dodson R, Jimenez MC, Behman R, Cocieru A, Blazer DG 3rd, Fisher SB, Squires MH 3rd, Kooby DA, Maithel SK, Groeschl RT, Gamblin TC, Bauer TW, Karanicolas PJ, Law C, Quereshy FA, Pawlik TM (2015). Adherence to Guidelines for Adjuvant Imatinib Therapy for GIST: A Multi-institutional Analysis. J Gastrointest Surg, 19(6), 1022-8. (Read full publication)
    88. Spolverato G, Kim Y, Ejaz A, Alexandrescu S, Marques H, Aldrighetti L, Gamblin TC, Pulitano C, Bauer TW, Shen F, Sandroussi C, Poultsides G, Maithel SK, Pawlik TM (2015). Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 535 Patients. JAMA Surg, 150(6), 538-45. (Read full publication)
    89. Kunnimalaiyaan S, Trevino J, Tsai S, Gamblin TC, Kunnimalaiyaan M (2015). Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells. Mol Cancer Ther, 14(6), 1395-403. (Read full publication)
    90. Soares KC, Kim Y, Spolverato G, Maithel S, Bauer TW, Marques H, Sobral M, Knoblich M, Tran T, Aldrighetti L, Jabbour N, Poultsides GA, Gamblin TC, Pawlik TM (2015). Presentation and Clinical Outcomes of Choledochal Cysts in Children and Adults: A Multi-institutional Analysis. JAMA Surg, 150(6), 577-84. (Read full publication)
    91. Kunnimalaiyaan S, Sokolowski KM, Balamurugan M, Gamblin TC, Kunnimalaiyaan M (2015). Xanthohumol inhibits Notch signaling and induces apoptosis in hepatocellular carcinoma. PLoS One, 10(5), e0127464. (Read full publication)
    92. Margonis GA, Spolverato G, Kim Y, Marques H, Poultsides G, Maithel S, Aldrighetti L, Bauer TW, Jabbour N, Gamblin TC, Soares K, Pawlik TM (2014). Minimally invasive resection of choledochal cyst: a feasible and safe surgical option. J Gastrointest Surg, 19(5), 858-65. (Read full publication)
    93. Bischof DA, Kim Y, Dodson R, Jimenez MC, Behman R, Cocieru A, Fisher SB, Groeschl RT, Squires MH 3rd, Maithel SK, Blazer DG 3rd, Kooby DA, Gamblin TC, Bauer TW, Quereshy FA, Karanicolas PJ, Law CH, Pawlik TM (2015). Conditional disease-free survival after surgical resection of gastrointestinal stromal tumors: a multi-institutional analysis of 502 patients. JAMA Surg, 150(4), 299-306. (Read full publication)
    94. Wilson JM, Kunnimalaiyaan S, Kunnimalaiyaan M, Gamblin TC (2015). Inhibition of the AKT pathway in cholangiocarcinoma by MK2206 reduces cellular viability via induction of apoptosis. Cancer Cell Int, 15(1), 13. (Read full publication)
    95. Arnaoutakis DJ, Kim Y, Pulitano C, Zaydfudim V, Squires MH, Kooby D, Groeschl R, Alexandrescu S, Bauer TW, Bloomston M, Soares K, Marques H, Gamblin TC, Popescu I, Adams R, Nagorney D, Barroso E, Maithel SK, Crawford M, Sandroussi C, Marsh W, Pawlik TM (2014). Management of biliary cystic tumors: a multi-institutional analysis of a rare liver tumor. Ann Surg, 261(2), 361-7. (Read full publication)
    96. Jayakrishnan TT, Nadeem H, Groeschl RT, George B, Thomas JP, Ritch PS, Christians KK, Tsai S, Evans DB, Pappas SG, Gamblin TC, Turaga KK (2014). Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argument. HPB (Oxford), 17(2), 131-9. (Read full publication)
    97. Green DE, Jayakrishnan TT, Hwang M, Pappas SG, Gamblin TC, Turaga KK (2015). Immunohistochemistry - microarray analysis of patients with peritoneal metastases of appendiceal or colorectal origin. Front Surg, 1, 50. (Read full publication)
    98. Amini A, Miura JT, Larrieux G, Tsai S, Turaga KK, Christians KK, Brasel KJ, Clark Gamblin T, Weissman DE, Nattinger AB, Johnston FM (2014). Palliative care training in surgical oncology and hepatobiliary fellowships: a national survey of the fellows. Ann Surg Oncol, 22(6), 1761-7. (Read full publication)
    99. Amini A, Miura JT, Jayakrishnan TT, Johnston FM, Tsai S, Christians KK, Gamblin TC, Turaga KK (2014). Is local resection adequate for T1 stage ampullary cancer? HPB (Oxford), 17(1), 66-71. (Read full publication)
    100. Miura JT, Xiu J, Thomas J, George B, Carron BR, Tsai S, Johnston FM, Turaga KK, Gamblin TC (2015). Tumor profiling of gastric and esophageal carcinoma reveal different treatment options. Cancer Biol Ther, 16(5), 764-9. (Read full publication)
    101. Jayakrishnan TT, Green DE, Hwang M, Zacharias AJ, Sharma A, Johnston FM, Gamblin TC, Turaga KK (2014). Effect of the experience of surgical chairpersons on departmental National Institutes of Health funding. J Surg Res, 192(2), 293-7. (Read full publication)
    102. Bischof DA, Kim Y, Behman R, Karanicolas PJ, Quereshy FA, Blazer DG 3rd, Maithel SK, Gamblin TC, Bauer TW, Pawlik TM (2014). A nomogram to predict disease-free survival after surgical resection of GIST. J Gastrointest Surg, 18(12), 2123-9. (Read full publication)
    103. Beyer AM, Durand MJ, Hockenberry J, Gamblin TC, Phillips SA, Gutterman DD (2014). An acute rise in intraluminal pressure shifts the mediator of flow-mediated dilation from nitric oxide to hydrogen peroxide in human arterioles. Am J Physiol Heart Circ Physiol, 307(11), H1587-93. (Read full publication)
    104. Miura JT, Johnston FM, Gamblin TC, Turaga KK (2014). Current trends in the management of malignant peritoneal mesothelioma. Ann Surg Oncol, 21(12), 3947-53. (Read full publication)
    105. Zhu AX, Borger DR, Kim Y, Cosgrove D, Ejaz A, Alexandrescu S, Groeschl RT, Deshpande V, Lindberg JM, Ferrone C, Sempoux C, Yau T, Poon R, Popescu I, Bauer TW, Gamblin TC, Gigot JF, Anders RA, Pawlik TM (2014). Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets. Ann Surg Oncol, 21(12), 3827-34. (Read full publication)
    106. Miura JT, Jayakrishnan TT, Amini A, Johnston FM, Tsai S, Erickson B, Quebbeman EJ, Christians KK, Evans DB, Gamblin TC, Turaga KK (2014). Defining the role of adjuvant external beam radiotherapy on resected adenocarcinoma of the ampulla of vater. J Gastrointest Surg, 18(11), 2003-8. (Read full publication)
    107. Krepline AN, Christians KK, Duelge K, Mahmoud A, Ritch P, George B, Erickson BA, Foley WD, Quebbeman EJ, Turaga KK, Johnston FM, Gamblin TC, Evans DB, Tsai S (2014). Patency rates of portal vein/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancer. J Gastrointest Surg, 18(11), 2016-25. (Read full publication)
    108. Miura JT, Amini A, Schmocker R, Nichols S, Sukato D, Winslow ER, Spolverato G, Ejaz A, Squires MH, Kooby DA, Maithel SK, Li A, Wu MC, Sarmiento JM, Bloomston M, Christians KK, Johnston FM, Tsai S, Turaga KK, Tsung A, Pawlik TM, Gamblin TC (2014). Surgical management of hepatic hemangiomas: a multi-institutional experience. HPB (Oxford), 16(10), 924-8. (Read full publication)
    109. Wilson JM, Kunnimalaiyaan S, Gamblin TC, Kunnimalaiyaan M (2014). MK2206 inhibits hepatocellular carcinoma cellular proliferation via induction of apoptosis and cell cycle arrest. J Surg Res, 191(2), 280-5. (Read full publication)
    110. Groeschl RT, Riggle KM, Quebbeman EJ, Christians KK, Turaga KK, Tsai S, Gamblin TC (2015). Hepatectomy for hemangioma; safe, but is it successful? Hepatogastroenterology, 61(135), 2009-13. (Read full publication)
    111. Bischof DA, Kim Y, Dodson R, Carolina Jimenez M, Behman R, Cocieru A, Blazer DG 3rd, Fisher SB, Squires MH 3rd, Kooby DA, Maithel SK, Groeschl RT, Clark Gamblin T, Bauer TW, Karanicolas PJ, Law C, Quereshy FA, Pawlik TM (2014). Open versus minimally invasive resection of gastric GIST: a multi-institutional analysis of short- and long-term outcomes. Ann Surg Oncol, 21(9), 2941-8. (Read full publication)
    112. Miura JT, Johnston FM, Thomas J, George B, Eastwood D, Tsai S, Christians KK, Turaga KK, Gamblin TC (2014). Molecular profiling in gastric cancer: examining potential targets for chemotherapy. J Surg Oncol, 110(3), 302-6. (Read full publication)
    113. Groeschl RT, Miura JT, Wong RK, Bloomston M, Lidsky ML, Clary BM, Martin RC, Belli G, Buell JF, Gamblin TC (2014). Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma. J Surg Oncol, 110(4), 412-5. (Read full publication)
    114. Bischof DA, Kim Y, Blazer DG 3rd, Behman R, Karanicolas PJ, Law CH, Quereshy FA, Maithel SK, Gamblin TC, Bauer TW, Pawlik TM (2014). Surgical management of advanced gastrointestinal stromal tumors: an international multi-institutional analysis of 158 patients. J Am Coll Surg, 219(3), 439-49. (Read full publication)
    115. Jayakrishnan TT, Zacharias AJ, Sharma A, Pappas SG, Gamblin TC, Turaga KK (2014). Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). World J Surg Oncol, 12, 270. (Read full publication)
    116. Nadeem H, Jayakrishnan TT, Groeschl RT, Zacharias A, Clark Gamblin T, Turaga KK (2014). Cost effectiveness of routine laparoscopic ultrasound for assessment of resectability of gallbladder cancer. Ann Surg Oncol, 21(7), 2413-9. (Read full publication)
    117. Spolverato G, Ejaz A, Kim Y, Sotiropoulos GC, Pau A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L, Bauer TW, Walters DM, Groeschl R, Gamblin TC, Marsh W, Nguyen KT, Turley R, Popescu I, Hubert C, Meyer S, Gigot JF, Mentha G, Pawlik TM (2014). Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma. J Gastrointest Surg, 18(7), 1284-91. (Read full publication)
    118. Hammond JS, Franko J, Holloway SE, Heckman JT, Orons PD, Gamblin TC (2014). Gemcitabine transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma. Hepatogastroenterology, 61(133), 1339-43. (Read full publication)
    119. Groeschl RT, Pilgrim CH, Hanna EM, Simo KA, Swan RZ, Sindram D, Martinie JB, Iannitti DA, Bloomston M, Schmidt C, Khabiri H, Shirley LA, Martin RC, Tsai S, Turaga KK, Christians KK, Rilling WS, Gamblin TC (2013). Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg, 259(6), 1195-200. (Read full publication)
    120. Carter YM, Kunnimalaiyaan S, Chen H, Gamblin TC, Kunnimalaiyaan M (2014). Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth. Cancer Biol Ther, 15(5), 510-5. (Read full publication)
    121. Turaga KK, Gamblin TC (2014). Regional therapies for advanced cancer. Ann Surg Oncol, 21(5), 1426-8. (Read full publication)
    122. Hyder O, Marques H, Pulitano C, Marsh JW, Alexandrescu S, Bauer TW, Gamblin TC, Sotiropoulos GC, Paul A, Barroso E, Clary BM, Aldrighetti L, Ferrone CR, Zhu AX, Popescu I, Gigot JF, Mentha G, Feng S, Pawlik TM (2014). A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg, 149(5), 432-8. (Read full publication)
    123. Butterfield LH, Economou JS, Gamblin TC, Geller DA (2014). Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients. J Transl Med, 12, 86. (Read full publication)
    124. Groeschl RT, Miura JT, Oshima K, Gamblin TC, Turaga KK (2013). Does histology predict outcome for malignant vascular tumors of the liver? J Surg Oncol, 109(5), 483-6. (Read full publication)
    125. Amini A, Gamblin TC (2013). Palliation: treating patients with inoperable biliary tract and primary liver tumors. Surg Oncol Clin N Am, 23(2), 383-97. (Read full publication)
    126. Sullivan KM, Groeschl RT, Turaga KK, Tsai S, Christians KK, White SB, Rilling WS, Pilgrim CH, Gamblin TC (2013). Neutrophil-to-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma: a Western perspective. J Surg Oncol, 109(2), 95-7. (Read full publication)
    127. Pappas SG, Christians KK, Tolat PP, Mautz AP, Lal A, McElroy L, Gamblin TC, Turaga KK, Tsai S, Erickson B, Ritch P, Evans DB (2013). Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility? HPB (Oxford), 16(1), 70-4. (Read full publication)
    128. Turaga KK, Green DE, Jayakrishnan TT, Hwang M, Gamblin TC (2013). Attributes of a surgical chairperson associated with extramural funding of a department of surgery. J Surg Res, 185(2), 549-54. (Read full publication)
    129. Miura JT, Evans DB, Pappas SG, Gamblin TC, Turaga KK (2013). Borderline resectable/locally advanced pancreatic adenocarcinoma: improvements needed in population-based registries. Ann Surg Oncol, 20(13), 4338-47. (Read full publication)
    130. Pappas SG, Pilgrim CH, Keim R, Harris R, Wilson S, Turaga K, Tsai S, Dua K, Khan A, Oh Y, Gamblin TC, Christians K (2013). The Frey procedure for chronic pancreatitis secondary to pancreas divisum. JAMA Surg, 148(11), 1057-62. (Read full publication)
    131. Groeschl RT, Gamblin TC, Turaga KK (2013). Ablation for hepatocellular carcinoma: validating the 3-cm breakpoint. Ann Surg Oncol, 20(11), 3591-5. (Read full publication)
    132. Groeschl RT, Hong JC, Christians KK, Turaga KK, Tsai S, Pilgrim CH, Gamblin TC (2013). Viral status at the time of liver transplantation for hepatocellular carcinoma: a modern predictor of longterm survival. HPB (Oxford), 15(10), 794-802. (Read full publication)
    133. Dilip A, Cheng G, Joseph J, Kunnimalaiyaan S, Kalyanaraman B, Kunnimalaiyaan M, Gamblin TC (2013). Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma. Anticancer Drugs, 24(9), 881-8. (Read full publication)
    134. Belli G, Gayet B, Han HS, Wakabayashi G, Kim KH, Cannon R, Kaneko H, Gamblin T, Koffron A, Dagher I, Buell JF, International Consensus Group for Laparoscopic Liver Surgery (2013). Laparoscopic left hemihepatectomy a consideration for acceptance as standard of care. Surg Endosc, 27(8), 2721-6. (Read full publication)
    135. Groeschl RT, Christians KK, Turaga KK, Gamblin TC (2012). Management of primary hepatopancreatobiliary small cell carcinoma. J Surg Oncol, 107(7), 692-5. (Read full publication)
    136. Groeschl RT, Clark Gamblin T, Turaga KK (2013). Surgical resection in hepatocellular carcinoma patients with minimal background fibrosis: a strategy in the era of organ shortage. Ann Surg Oncol, 20(6), 2043-8. (Read full publication)
    137. Hyder O, Hatzaras I, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L, Ferrone CR, Zhu AX, Bauer TW, Walters DM, Groeschl R, Gamblin TC, Marsh JW, Nguyen KT, Turley R, Popescu I, Hubert C, Meyer S, Choti MA, Gigot JF, Mentha G, Pawlik TM (2013). Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery, 153(6), 811-8. (Read full publication)
    138. Groeschl RT, Turaga KK, Gamblin TC (2013). Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma. J Surg Oncol, 107(6), 608-12. (Read full publication)
    139. Groeschl RT, Wong RK, Quebbeman EJ, Tsai S, Turaga KK, Pappas SG, Christians KK, Hohenwalter EJ, Tutton SM, Rilling WS, Gamblin TC (2012). Recurrence after microwave ablation of liver malignancies: a single institution experience. HPB (Oxford), 15(5), 365-71. (Read full publication)
    140. Turaga KK, Tsai S, Wiebe LA, Evans DB, Gamblin TC (2012). Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma. Ann Surg Oncol, 20(4), 1230-9. (Read full publication)
    141. Turaga KK, Pappas S, Gamblin TC (2013). Right hemicolectomy for mucinous adenocarcinoma of the appendix: just right or too much? Ann Surg Oncol, 20(4), 1063-7. (Read full publication)
    142. Wilson JM, Groeschl R, George B, Turaga KK, Patel PJ, Saeian K, Gamblin TC (2013). Ciliated hepatic cyst leading to squamous cell carcinoma of the liver - A case report and review of the literature. Int J Surg Case Rep, 4(11), 972-5. (Read full publication)
    143. Peng PD, Hyder O, Mavros MN, Turley R, Groeschl R, Firoozmand A, Lidsky M, Herman JM, Choti M, Ahuja N, Anders R, Blazer DG 3rd, Gamblin TC, Pawlik TM (2012). Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients. Ann Surg Oncol, 19(13), 4036-42. (Read full publication)
    144. Johnston FM, Kneuertz PJ, Cameron JL, Sanford D, Fisher S, Turley R, Groeschl R, Hyder O, Kooby DA, Blazer D 3rd, Choti MA, Wolfgang CL, Gamblin TC, Hawkins WG, Maithel SK, Pawlik TM (2012). Presentation and management of gastrointestinal stromal tumors of the duodenum: a multi-institutional analysis. Ann Surg Oncol, 19(11), 3351-60. (Read full publication)
    145. Vanounou T, Groeschl RT, Geller DA, Marsh JW, Gamblin TC (2012). Economic model of observation versus immediate resection of hepatic adenomas. J Surg Oncol, 106(4), 491-7. (Read full publication)
    146. Turaga KK, Gamblin TC (2012). Measuring the surgical academic output of an institution: the "institutional" H-index. J Surg Educ, 69(4), 499-503. (Read full publication)
    147. Turaga KK, Pappas SG, Gamblin T (2011). Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol, 19(5), 1379-85. (Read full publication)
    148. Groeschl RT, Nachmany I, Steel JL, Reddy SK, Glazer ES, de Jong MC, Pawlik TM, Geller DA, Tsung A, Marsh JW, Clary BM, Curley SA, Gamblin TC (2012). Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. J Am Coll Surg, 214(5), 769-77. (Read full publication)
    149. Turaga KK, Gamblin TC, Pappas S (2012). Surgical treatment of peritoneal carcinomatosis from gastric cancer. Int J Surg Oncol, 2012, 405652. (Read full publication)
    150. Mayo SC, de Jong MC, Bloomston M, Pulitano C, Clary BM, Reddy SK, Clark Gamblin T, Celinski SA, Kooby DA, Staley CA, Stokes JB, Chu CK, Arrese D, Ferrero A, Schulick RD, Choti MA, Geschwind JF, Strub J, Bauer TW, Adams RB, Aldrighetti L, Mentha G, Capussotti L, Pawlik TM (2011). Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. Ann Surg Oncol, 18(13), 3657-65. (Read full publication)
    151. Kitisin K, Packiam V, Steel J, Humar A, Gamblin TC, Geller DA, Marsh JW, Tsung A (2011). Presentation and outcomes of hepatocellular carcinoma patients at a western centre. HPB (Oxford), 13(10), 712-22. (Read full publication)
    152. de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L, Ferrone CR, Zhu AX, Bauer TW, Walters DM, Gamblin TC, Nguyen KT, Turley R, Popescu I, Hubert C, Meyer S, Schulick RD, Choti MA, Gigot JF, Mentha G, Pawlik TM (2011). Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol, 29(23), 3140-5. (Read full publication)
    153. Steel J, Geller DA, Tsung A, Marsh JW, Dew MA, Spring M, Grady J, Likumahuwa S, Dunlavy A, Youssef M, Antoni M, Butterfield LH, Schulz R, Day R, Helgeson V, Kim KH, Gamblin TC (2011). Randomized controlled trial of a collaborative care intervention to manage cancer-related symptoms: lessons learned. Clin Trials, 8(3), 298-310. (Read full publication)
    154. Moore AM, Gamblin TC, Geller DA, Youssef MN, Hoffman KE, Gemmell L, Likumahuwa SM, Bovbjerg DH, Marsland A, Steel JL (2010). A prospective study of posttraumatic growth as assessed by self-report and family caregiver in the context of advanced cancer. Psychooncology, 20(5), 479-87. (Read full publication)
    155. Reddy SK, Barbas AS, Turley RS, Gamblin TC, Geller DA, Marsh JW, Tsung A, Clary BM, Lagoo-Deenadayalan S (2011). Major liver resection in elderly patients: a multi-institutional analysis. J Am Coll Surg, 212(5), 787-95. (Read full publication)
    156. Cho SW, Steel J, Tsung A, Marsh JW, Geller DA, Gamblin TC (2010). Safety of liver resection in the elderly: how important is age? Ann Surg Oncol, 18(4), 1088-95. (Read full publication)
    157. Nguyen KT, Kitisin K, Steel J, Jeyabalan G, Aggarwal S, Geller DA, Gamblin TC (2011). Cirrhosis is not a contraindication to laparoscopic cholecystectomy: results and practical recommendations. HPB (Oxford), 13(3), 192-7. (Read full publication)
    158. Nace GW, Steel JL, Amesur N, Zajko A, Nastasi BE, Joyce J, Sheetz M, Gamblin TC (2011). Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience. Int J Surg Oncol, 2011, 571261. (Read full publication)
    159. Mayo SC, de Jong MC, Pulitano C, Clary BM, Reddy SK, Gamblin TC, Celinksi SA, Kooby DA, Staley CA, Stokes JB, Chu CK, Ferrero A, Schulick RD, Choti MA, Mentha G, Strub J, Bauer TW, Adams RB, Aldrighetti L, Capussotti L, Pawlik TM (2010). Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol, 17(12), 3129-36. (Read full publication)
    160. Steel JL, Kim KH, Dew MA, Unruh ML, Antoni MH, Olek MC, Geller DA, Carr BI, Butterfield LH, Gamblin TC (2008). Cancer-related symptom clusters, eosinophils, and survival in hepatobiliary cancer: an exploratory study. J Pain Symptom Manage, 39(5), 859-71. (Read full publication)
    161. Vanounou T, Steel JL, Nguyen KT, Tsung A, Marsh JW, Geller DA, Gamblin TC (2009). Comparing the clinical and economic impact of laparoscopic versus open liver resection. Ann Surg Oncol, 17(4), 998-1009. (Read full publication)
    162. Cho SW, Kitisin K, Buck D, Steel J, Brufsky A, Gillespie R, Tsung A, Marsh JW, Geller DA, Gamblin TC (2010). Transcatheter arterial chemoembolization is a feasible palliative locoregional therapy for breast cancer liver metastases. Int J Surg Oncol, 2010, 251621. (Read full publication)
    163. Nguyen KT, Steel J, Vanounou T, Tsung A, Marsh JW, Geller DA, Gamblin TC (2009). Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection? Ann Surg Oncol, 16(12), 3308-15. (Read full publication)
    164. Dagher I, ORourke N, Geller DA, Cherqui D, Belli G, Gamblin TC, Lainas P, Laurent A, Nguyen KT, Marvin MR, Thomas M, Ravindra K, Fielding G, Franco D, Buell JF (2009). Laparoscopic major hepatectomy: an evolution in standard of care. Ann Surg, 250(5), 856-60. (Read full publication)
    165. Nguyen KT, Laurent A, Dagher I, Geller DA, Steel J, Thomas MT, Marvin M, Ravindra KV, Mejia A, Lainas P, Franco D, Cherqui D, Buell JF, Gamblin TC (2009). Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes. Ann Surg, 250(5), 842-8. (Read full publication)
    166. Buell JF, Cherqui D, Geller DA, ORourke N, Iannitti D, Dagher I, Koffron AJ, Thomas M, Gayet B, Han HS, Wakabayashi G, Belli G, Kaneko H, Ker CG, Scatton O, Laurent A, Abdalla EK, Chaudhury P, Dutson E, Gamblin C, DAngelica M, Nagorney D, Testa G, Labow D, Manas D, Poon RT, Nelson H, Martin R, Clary B, Pinson WC, Martinie J, Vauthey JN, Goldstein R, Roayaie S, Barlet D, Espat J, Abecassis M, Rees M, Fong Y, McMasters KM, Broelsch C, Busuttil R, Belghiti J, Strasberg S, Chari RS, World Consensus Conference on Laparoscopic Surgery (2009). The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg, 250(5), 825-30. (Read full publication)
    167. Cardinal J, de Vera ME, Marsh JW, Steel JL, Geller DA, Fontes P, Nalesnik M, Gamblin TC (2009). Treatment of hepatic epithelioid hemangioendothelioma: a single-institution experience with 25 cases. Arch Surg, 144(11), 1035-9. (Read full publication)
    168. Dhupar R, de Vera ME, Marsh JW, Fontes PA, Steel JL, Zeh HJ, Gamblin TC (2008). Simultaneous pancreatectomy and liver transplantation: a single-institution experience. HPB (Oxford), 11(3), 242-6. (Read full publication)
    169. Gamblin TC, Krasinskas AM, Slivka AS, Tublin ME, Demetris J, Shue E, Caro S, Marsh JW, James Moser A (2008). Fibroinflammatory biliary stricture: a rare bile duct lesion masquerading as cholangiocarcinoma. J Gastrointest Surg, 13(4), 713-21. (Read full publication)
    170. Bark K, Gamblin TC, Zuckerman R, Geller DA (2008). Operative choledochoscopic laser lithotripsy for impacted intrahepatic gallstones: a novel surgical approach. Surg Endosc, 23(1), 221-4. (Read full publication)
    171. Dhupar R, Gulack B, Geller DA, Marsh JW, Gamblin TC (2009). The changing presentation of choledochal cyst disease: an incidental diagnosis. HPB Surg, 2009, 103739. (Read full publication)
    172. Cho SW, Marsh JW, Geller DA, Holtzman M, Zeh H 3rd, Bartlett DL, Gamblin TC (2008). Surgical management of leiomyosarcoma of the inferior vena cava. J Gastrointest Surg, 12(12), 2141-8. (Read full publication)
    173. Heckman JT, Devera MB, Marsh JW, Fontes P, Amesur NB, Holloway SE, Nalesnik M, Geller DA, Steel JL, Gamblin TC (2008). Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann Surg Oncol, 15(11), 3169-77. (Read full publication)
    174. Gamblin TC, Holloway SE, Heckman JT, Geller DA (2008). Laparoscopic resection of benign hepatic cysts: a new standard. J Am Coll Surg, 207(5), 731-6. (Read full publication)
    175. Cho SW, Marsh JW, Steel J, Holloway SE, Heckman JT, Ochoa ER, Geller DA, Gamblin TC (2008). Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol, 15(10), 2795-803. (Read full publication)
    176. Gamblin TC, Egorin MJ, Zuhowski EG, Lagattuta TF, Herscher LL, Russo A, Libutti SK, Alexander HR, Dedrick RL, Bartlett DL (2007). Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas. Cancer Chemother Pharmacol, 62(4), 647-53. (Read full publication)
    177. Odoux C, Fohrer H, Hoppo T, Guzik L, Stolz DB, Lewis DW, Gollin SM, Gamblin TC, Geller DA, Lagasse E (2008). A stochastic model for cancer stem cell origin in metastatic colon cancer. Cancer Res, 68(17), 6932-41. (Read full publication)
    178. Steel JL, Gamblin TC, Carr BI (2008). Measuring post-traumatic growth in people diagnosed with hepatobiliary cancer: directions for future research. Oncol Nurs Forum, 35(4), 643-50. (Read full publication)
    179. Li R, Walvekar RR, Nalesnik MA, Gamblin TC (2008). Unresectable hepatocellular carcinoma with a solitary metastasis to the mandible. Am Surg, 74(4), 346-9. (Read full publication)
    180. Balaa FK, Gamblin TC, Tsung A, Marsh JW, Geller DA (2007). Right hepatic lobectomy using the staple technique in 101 patients. J Gastrointest Surg, 12(2), 338-43. (Read full publication)
    181. Cho SW, Marsh JW, Fontes PA, Daily MF, Nalesnik M, Tublin M, De Vera ME, Geller DA, Gamblin TC (2007). Extrahepatic portal vein aneurysm--report of six patients and review of the literature. J Gastrointest Surg, 12(1), 145-52. (Read full publication)
    182. Gusani NJ, Balaa FK, Steel JL, Geller DA, Marsh JW, Zajko AB, Carr BI, Gamblin TC (2007). Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience. J Gastrointest Surg, 12(1), 129-37. (Read full publication)
    183. Adkins JR, Gamblin TC, Christie DB, Collings C, Dalton ML, Dale PS (2007). Mammography as screening for coronary artery disease. Am Surg, 73(7), 717-21. (Read full publication)
    184. Steel JL, Geller DA, Gamblin TC, Olek MC, Carr BI (2007). Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol, 25(17), 2397-405. (Read full publication)
    185. Tublin ME, Moser AJ, Marsh JW, Gamblin TC (2006). Biliary inflammatory pseudotumor: imaging features in seven patients. AJR Am J Roentgenol, 188(1), W44-8. (Read full publication)
    186. Gamblin TC, Edington H, Kirkwood JM, Rao UN (2006). Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features. Ann Surg Oncol, 13(12), 1664-70. (Read full publication)
    187. Koffron A, Geller D, Gamblin TC, Abecassis M (2006). Laparoscopic liver surgery: Shifting the management of liver tumors. Hepatology, 44(6), 1694-700. (Read full publication)
    188. Gamblin TC, Finkelstein SD, Upsal N, Kaye JD, Blumberg D (2006). Microdissection-based allelotyping: a novel technique to determine the temporal sequence and biological aggressiveness of colorectal cancer. Am Surg, 72(5), 445-53. (Read full publication)
    189. Gamblin TC, Nobles-James C, Bradley RA, Katner HP, Dale PS (2005). Cat scratch disease presenting as breast mastitis. Can J Surg, 48(3), 254-5. (Read full publication)
    190. Morgan JH 3rd, Royer GM, Hackett P, Gamblin TC, McCampbell BL, Conforti A, Dale PS (2005). Radio-frequency ablation of large, nonresectable hepatic tumors. Am Surg, 70(12), 1035-8. (Read full publication)
    191. Gamblin TC, Wall CE Jr, Morgan JH 3rd, Erickson DJ, Dalton ML, Ashley DW (2004). The natural history of untreated penetrating diaphragm injury: an animal model. J Trauma, 57(5), 989-92. (Read full publication)
    192. Ashley DW, Gamblin TC, McCampbell BL, Kitchens DM, Dalton ML Jr, Solis MM (2004). Bedside insertion of vena cava filters in the intensive care unit using intravascular ultrasound to locate renal veins. J Trauma, 57(1), 26-31. (Read full publication)
    193. Morgan JH 3rd, Gamblin TC, Adkins JR, Groves JR, Dalton ML, Ashley DW (2004). Norepinephrine is a more potent inhibitor of tumor necrosis factor over a range of doses than dopamine. Am Surg, 70(6), 526-8. (Read full publication)
    194. Young HE, Duplaa C, Yost MJ, Henson NL, Floyd JA, Detmer K, Thompson AJ, Powell SW, Gamblin TC, Kizziah K, Holland BJ, Boev A, Van De Water JM, Godbee DC, Jackson S, Rimando M, Edwards CR, Wu E, Cawley C, Edwards PD, Macgregor A, Bozof R, Thompson TM, Petro GJ Jr, Shelton HM, McCampbell BL, Mills JC, Flynt FL, Steele TA, Kearney M, Kirincich-Greathead A, Hardy W, Young PR, Amin AV, Williams RS, Horton MM, McGuinn S, Hawkins KC, Ericson K, Terracio L, Moreau C, Hixson D, Tobin BW, Hudson J, Bowyer FP 3rd, Black AC Jr (2004). Clonogenic analysis reveals reserve stem cells in postnatal mammals. II. Pluripotent epiblastic-like stem cells. Anat Rec A Discov Mol Cell Evol Biol, 277(1), 178-203. (Read full publication)
    195. Gamblin TC, Dalton ML, Morgan JH 3rd, Christie DB 3rd, Vogel RL, Dale PS (2004). Impact of a surgical oncologist on general surgery residency training program. Am J Surg, 187(1), 73-5. (Read full publication)
    196. Gamblin TC, Jennings GR, Christie DB 3rd, Thompson WM Jr, Dalton ML (2003). Ectopic thyroid. Ann Thorac Surg, 75(6), 1952-3. (Read full publication)
    197. Gamblin TC, Ashley DW, Burch S, Solis M (2003). A prospective evaluation of a bedside technique for placement of inferior vena cava filters: accuracy and limitations of intravascular ultrasound. Am Surg, 69(5), 382-6. (Read full publication)
    198. Gamblin TC, McKinney WB, Stephens RE Jr, Barron T (2002). Perineuroma of the scrotum. Urology, 60(3), 515. (Read full publication)
    199. Gamblin TC, Dalton ML (2005). Flail chest caused by penetrating trauma: a case report. Curr Surg, 59(4), 418-9. (Read full publication)
    200. Lane JE, Gamblin TC, Solis M, Barron T (2005). Laparoscopic orchiectomy for unilateral intra-abdominal testis. Curr Surg, 59(3), 333-5. (Read full publication)
    201. Zunzunegui RG, Werner AM, Gamblin TC, Stephens JL, Ashley DW (2002). Colorectal blowout from compressed air: case report. J Trauma, 52(4), 793-5. (Read full publication)
    202. Gamblin TC, Farmer LA, Dean RJ, Bradley RA, Dalton ML (2002). Tracheal polyp. Ann Thorac Surg, 73(4), 1286-7. (Read full publication)
    203. Gabriel SA, McDaniel B, Ashley DW, Dalton ML, Gamblin TC (2001). Magnetically guided nasoenteral feeding tubes: a new technique. Am Surg, 67(6), 544-8; discussion 548-9. (Read full publication)
    204. Ashley DW, Gamblin TC, Burch ST, Solis MM (2001). Accurate deployment of vena cava filters: comparison of intravascular ultrasound and contrast venography. J Trauma, 50(6), 975-81. (Read full publication)
    205. Lyew MA, Gamblin TC, Ayoub M (2000). Systemic anaphylaxis associated with intramammary isosulfan blue injection used for sentinel node detection under general anesthesia. Anesthesiology, 93(4), 1145-6. (Read full publication)

    Review

    1. Gamboa AC, Kooby DA, Maithel SK, Gamblin TC (2023). Immune checkpoint inhibitors in hepatocellular carcinoma: A review of current clinical trials. [Review]. J Surg Oncol, 129(1), 63-70. (Read full publication)
    2. Lundberg RK, Elftmann AE, Wilson SD, Gamblin TC (2023). The Connell Stitch: A Two-Generation Contribution to Gastrointestinal Surgery. [Review]. Am Surg, 89(12), 6449-6451. (Read full publication)
    3. Baker T, Tabrizian P, Zendejas I, Gamblin TC, Kazimi M, Boudjema K, Geller D, Salem R (2021). Conversion to resection post radioembolization in patients with HCC: recommendations from a multidisciplinary working group. [Review]. HPB (Oxford), 24(7), 1007-1018. (Read full publication)
    4. Tsai S, Gamblin TC (2019). Molecular Characteristics of Biliary Tract and Primary Liver Tumors. [Review]. Surg Oncol Clin N Am, 28(4), 685-693. (Read full publication)
    5. Bliss LA, Strong EA, Gamblin TC (2019). Surgical resectability of multisite metastatic colorectal cancer: Pushing the limits while appropriately selecting patients. [Review]. J Surg Oncol, 119(5), 623-628. (Read full publication)
    6. Cheng H, Miura JT, Lalehzari M, Rajeev R, Donahue AE, Bedi M, Gamblin TC, Turaga KK, Johnston FM (2016). Neoadjuvant radiotherapy for retroperitoneal sarcoma: A systematic review. [Review]. J Surg Oncol, 113(6), 628-34. (Read full publication)
    7. Rajeev R, Gamblin TC, Turaga KK (2016). Hepatic Perfusion Therapy. [Review]. Surg Clin North Am, 96(2), 357-68. (Read full publication)
    8. Hammad AY, Miura JT, Turaga KK, Johnston FM, Hohenwalter MD, Gamblin TC (2016). A literature review of radiological findings to guide the diagnosis of gallbladder adenomyomatosis. [Review]. HPB (Oxford), 18(2), 129-135. (Read full publication)
    9. Sokolowski KM, Koprowski S, Kunnimalaiyaan S, Balamurugan M, Gamblin TC, Kunnimalaiyaan M (2015). Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer. [Review]. Anticancer Agents Med Chem, 16(1), 29-37. (Read full publication)
    10. Koprowski S, Sokolowski K, Kunnimalaiyaan S, Gamblin TC, Kunnimalaiyaan M (2015). Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma. [Review]. J Surg Res, 198(2), 434-40. (Read full publication)
    11. Helm JH, Miura JT, Glenn JA, Marcus RK, Larrieux G, Jayakrishnan TT, Donahue AE, Gamblin TC, Turaga KK, Johnston FM (2014). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. [Review]. Ann Surg Oncol, 22(5), 1686-93. (Read full publication)
    12. Boehm LM, Jayakrishnan TT, Miura JT, Zacharias AJ, Johnston FM, Turaga KK, Gamblin TC (2014). Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma. [Review]. J Surg Oncol, 111(2), 213-20. (Read full publication)
    13. Miura JT, Gamblin TC (2014). Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis. [Review]. Surg Oncol Clin N Am, 24(1), 149-66. (Read full publication)
    14. Shariat-Madar B, Jayakrishnan TT, Gamblin TC, Turaga KK (2014). Surgical management of bowel obstruction in patients with peritoneal carcinomatosis. [Review]. J Surg Oncol, 110(6), 666-9. (Read full publication)
    15. North DA, Groeschl RT, Sindram D, Martinie JB, Iannitti DA, Bloomston M, Schmidt C, Rilling WS, Gamblin TC, Martin RC (2014). Microwave ablation for hepatic malignancies: a call for standard reporting and outcomes. [Review]. Am J Surg, 208(2), 284-94. (Read full publication)
    16. Hwang M, Jayakrishnan TT, Green DE, George B, Thomas JP, Groeschl RT, Erickson B, Pappas SG, Gamblin TC, Turaga KK (2014). Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease. [Review]. Eur J Cancer, 50(10), 1747-1757. (Read full publication)
    17. Jayakrishnan TT, Groeschl RT, George B, Thomas JP, Pappas S, Gamblin TC, Turaga KK (2014). Management of acute cholecystitis in cancer patients: a comparative effectiveness approach. [Review]. Surg Endosc, 28(5), 1505-14. (Read full publication)
    18. Jayakrishnan TT, Groeschl RT, George B, Thomas JP, Clark Gamblin T, Turaga KK (2013). Review of the impact of antineoplastic therapies on the risk for cholelithiasis and acute cholecystitis. [Review]. Ann Surg Oncol, 21(1), 240-7. (Read full publication)
    19. Maithel SK, Gamblin TC, Kamel I, Corona-Villalobos CP, Thomas M, Pawlik TM (2013). Multidisciplinary approaches to intrahepatic cholangiocarcinoma. [Review]. Cancer, 119(22), 3929-42. (Read full publication)
    20. Pilgrim CH, Groeschl RT, Christians KK, Gamblin TC (2013). Modern perspectives on factors predisposing to the development of gallbladder cancer. [Review]. HPB (Oxford), 15(11), 839-44. (Read full publication)
    21. Pilgrim CH, Groeschl RT, Turaga KK, Gamblin TC (2013). Key factors influencing prognosis in relation to gallbladder cancer. [Review]. Dig Dis Sci, 58(9), 2455-62. (Read full publication)
    22. Caldow Pilgrim CH, Groeschl RT, Quebbeman EJ, Gamblin TC (2013). Recent advances in systemic therapies and radiotherapy for gallbladder cancer. [Review]. Surg Oncol, 22(1), 61-7. (Read full publication)
    23. Pilgrim CH, Groeschl RT, Pappas SG, Gamblin TC (2012). An often overlooked diagnosis: imaging features of gallbladder cancer. [Review]. J Am Coll Surg, 216(2), 333-9. (Read full publication)
    24. Gamblin TC, Christians K, Pappas SG (2010). Radiofrequency ablation of neuroendocrine hepatic metastasis. [Review]. Surg Oncol Clin N Am, 20(2), 273-9, vii-viii. (Read full publication)
    25. Nguyen KT, Marsh JW, Tsung A, Steel JJ, Gamblin TC, Geller DA (2010). Comparative benefits of laparoscopic vs open hepatic resection: a critical appraisal. [Review]. Arch Surg, 146(3), 348-56. (Read full publication)
    26. Parent BA, Cho SW, Buck DG, Nalesnik MA, Gamblin TC (2011). Spontaneous rupture of hepatic artery aneurysm associated with polyarteritis nodosa. [Review]. Am Surg, 76(12), 1416-9. (Read full publication)
    27. Celinski SA, Gamblin TC (2010). Hepatic resection nomenclature and techniques. [Review]. Surg Clin North Am, 90(4), 737-48. (Read full publication)
    28. Nguyen KT, Gamblin TC, Geller DA (2009). World review of laparoscopic liver resection-2,804 patients. [Review]. Ann Surg, 250(5), 831-41. (Read full publication)
    29. Amesur N, Hammond JS, Zajko AB, Geller DA, Gamblin TC (2008). Management of unresectable symptomatic focal nodular hyperplasia with arterial embolization. [Review]. J Vasc Interv Radiol, 20(4), 543-7. (Read full publication)
    30. Nguyen KT, Gamblin TC, Geller DA (2008). Laparoscopic liver resection for cancer. [Review]. Future Oncol, 4(5), 661-70. (Read full publication)
    31. Gusani NJ, Marsh JW, Nalesnik MA, Tublin ME, Gamblin TC (2008). Carcinoid of the extra-hepatic bile duct: a case report with long-term follow-up and review of literature. [Review]. Am Surg, 74(1), 87-90. (Read full publication)
    32. Gamblin TC, Stephens RE Jr, Johnson RK, Rothwell M (2004). Adult malrotation: a case report and review of the literature. [Review]. Curr Surg, 60(5), 517-20. (Read full publication)
    33. Gamblin TC, Glenn J, Herring D, McKinney WB (2004). Bowel obstruction caused by a Meckel's diverticulum enterolith: a case report and review of the literature. [Review]. Curr Surg, 60(1), 63-4. (Read full publication)

    Editorial

    1. Gamblin TC (2019). Hepatobiliary Malignancies: The Changing Landscape. Surg Oncol Clin N Am, 28(4), xv. (Read full publication)
    2. Gamblin TC (2019). Hepatobiliary Malignancies: The Changing Landscape. Surg Oncol Clin N Am, 28(4), xv. (Read full publication)
    3. Turaga KK, Gamblin TC, Edwards R, Alexander HR, Bartlett D (2019). It Is Time. Ann Surg Oncol, 26(7), 1963-1966. (Read full publication)
    4. Turaga KK, Clark Gamblin T, Richard Alexander H, Edwards R, Bartlett DL (2018). Together We Make a Difference. Ann Surg Oncol, 25(7), 1794-1796. (Read full publication)
    5. Turaga KK, Clark Gamblin T, Edwards R, Richard Alexander H, Bartlett DL (2017). Ushering in a New Era for Regional Therapies. Ann Surg Oncol, 24(4), 868-869. (Read full publication)
    6. Bagante F, Gamblin TC, Pawlik TM (2016). Cholangiocarcinoma risk factors and the potential role of aspirin. Hepatology, 64(3), 708-10. (Read full publication)
    7. Turaga KK, Gamblin TC, Alexander HR, Edwards R, Bartlett DL (2016). Regional Therapies for Advanced Cancer: Update for 2016. Ann Surg Oncol, 23(5), 1452-3. (Read full publication)
    8. Turaga KK, Clark Gamblin T, Richard Alexander H, Edwards R, Bartlett DL (2015). Moving fast and moving slow. Ann Surg Oncol, 22(5), 1631-3. (Read full publication)
    9. Gamblin TC, Alexander HR, Edwards R, Bartlett DL (2013). Regional therapies for cancer. Ann Surg Oncol, 20(4), 1053-5. (Read full publication)
    10. Gamblin T, Alexander H, Edwards R, Bartlett DL (2012). Concepts of regional therapies for advanced malignancy. Ann Surg Oncol, 19(5), 1371-2. (Read full publication)
    11. Geller DA, Tsung A, Marsh JW, Dvorchik I, Gamblin TC, Carr BI (2005). Outcome of 1000 liver cancer patients evaluated at the UPMC Liver Cancer Center. J Gastrointest Surg, 10(1), 63-8. (Read full publication)
    12. Gamblin TC, Santos RS, Baratz M, Landreneau RJ (2006). Metastatic colon cancer to the hand. Am Surg, 72(1), 98-100. (Read full publication)
    13. Gamblin TC, Geller DA (2005). Downstaging hepatocellular carcinoma prior to liver transplantation. Liver Transpl, 11(12), 1466-8. (Read full publication)
    14. Gamblin TC, Wall CE Jr, Royer GM, Dalton ML, Ashley DW (2005). Delayed splenic rupture: case reports and review of the literature. J Trauma, 59(5), 1231-4. (Read full publication)